About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Enrolling By InvitationNCT05889806

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)

Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, d...

Lead sponsor: Audubon Bioscience•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Audubon Bioscience

The primary objective of this Study is to collect high-quality tissue, whole teeth, and biofluid Specimens, and associated Clinical Data from consented Subjects. The secondary objective of this Study is to test Specimens and associated Clinical Data to confirm pathology diagnosis and correlation of microscopic evaluation with the provided information, to assess RNA and DNA integrity or degradation, and provide overall quality control evaluations.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Subject shall be at least 18 years of age, or higher if required by Applicable Law.
•2. Subject's Clinical Data shall be relevant to the Study in which he/she is participating.
•3. Subject shall understand and voluntarily sign the ICF prior to the Study participation. If the Subject is illiterate, the witness must sign the ICF (see 5.6. for details). If the Subject is incapable of consenting himself/herself, the legally authorized representative must sign the ICF (see 5.6. for details).
•5. Subject shall be able to donate the requested Specimen(s) without compromising his/her current health status.

Exclusion Criteria

•1. Younger than 18 years of age, or higher if required by Applicable Law.
•2. The individual is incapable of understanding the items listed in the ICF and the consent process unless consented by the legally authorized representative.
•3. Prisoner

Related studies

A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

NCT06815120 · Catheter Blockage, Oncology, and more

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

NCT05417971 · Hematologic Malignancy

RECRUITINGPhase 2

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

NCT06237816 · Cancer, Oncology

RECRUITINGPhase 2

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

NCT05529069 · Mantle Cell Lymphoma, Non Hodgkin Lymphoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 5, 2023Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment10,000

Start dateMay 2023

Last updatedJun 5, 2023

Condition

Oncology Hematologic Malignancy Gastro-Intestinal Disorder Autoimmune Diseases Pregnancy Related+4 more

Locations shown

AUD

New Orleans, Louisiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions